COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Coronavirus Guidance for NIH Applicants and Grantees:


Division of Receipt and Referral – DRR

Dr. Cathleen Cooper is the Director, Division of Receipt and Referral (DRR) at the Center for Scientific Review. She came to this position after serving as Chief of the Oncology 1: Basic Translational Integrated Review Group for several years. Earlier in her NIH career, she spent eight years as a Scientific Review Officer for CSR’s Experimental Immunology and Transplantation, Tolerance, and Tumor Immunology study sections as well as a Referral Officer in DRR. Dr. Cooper earned a Ph.D. in pathology at the University of Southern California where she studied naturally occurring delayed-type hypersensitivity reactions to mycobacteria. She did her postdoctoral training in molecular immunology at Columbia University then went to the University of Massachusetts Medical School as an assistant professor in the Department of Cell Biology and the Cancer Center. There, she led a research team studying the molecular regulation of early events in hematopoietic development with special emphasis on B lymphocyte and neutrophil differentiation. Her work was funded by NIH, American Cancer Society, and private foundations.